Embryonic abnormalities at medical termination of pregnancy with mifepristone and misoprostol during first trimester: observational study

A study found a potential loss rate for embryos with structural abnormalities or other non-viable conditions of 34%. It is difficult to calculate the true rate of spontaneous miscarriage.

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BMJ 1998-06, Vol.316 (7146), p.1712-1713
Hauptverfasser:	Blanch, G, Quenby, S, Ballantyne, E S, Gosden, C M, Neilson, J P, Holland, K
Format:	Artikel
Sprache:	eng
Schlagworte:	Abortifacient Agents, Nonsteroidal Abortifacient Agents, Steroidal Abortion Abortion, Induced - methods Administration, Oral Adolescent Biological and medical sciences Birth defects Day care Diseases of mother, fetus and pregnancy Drug Combinations Embryos Female Fetus - abnormalities Fetuses First trimester of pregnancy Gynecology. Andrology. Obstetrics Humans Medical sciences Mifepristone Miscarriage Misoprostol Neural tube defects Patient assessment Population Pregnancy Pregnancy Trimester, First Pregnancy. Fetus. Placenta Prenatal development Specimens
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A study found a potential loss rate for embryos with structural abnormalities or other non-viable conditions of 34%. It is difficult to calculate the true rate of spontaneous miscarriage.
ISSN:	0959-8138 0959-8146 1468-5833 1756-1833
DOI:	10.1136/bmj.316.7146.1712